These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Giant cell myocarditis triggered by a parvovirus B19 infection. Dennert R; Schalla S; Suylen RJ; Eurlings L; Heymans S Int J Cardiol; 2009 May; 134(1):115-6. PubMed ID: 18280593 [TBL] [Abstract][Full Text] [Related]
25. Eosinophilia-myalgia syndrome and giant cell myocarditis: a case report and therapeutic approach. Amidon TM; Baldwin JL; George E Heart Dis; 1999; 1(2):66-7. PubMed ID: 11720607 [TBL] [Abstract][Full Text] [Related]
26. [Pathogenesis of human chronic chagasic myocarditis]. Laguens RP; Cabeza Meckert PM; Vigliano CA Medicina (B Aires); 1999; 59 Suppl 2():63-8. PubMed ID: 10668245 [TBL] [Abstract][Full Text] [Related]
27. Isolated giant cell myocarditis in the atrium: an incidental finding? Ahmad I; Craig Miller D; Berry GJ; Hsia HH; Wang PJ; Al-Ahmad A Pacing Clin Electrophysiol; 2006 Oct; 29(10):1179-80. PubMed ID: 17038151 [TBL] [Abstract][Full Text] [Related]
28. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Magnani JW; Danik HJ; Dec GW; DiSalvo TG Am Heart J; 2006 Feb; 151(2):463-70. PubMed ID: 16442915 [TBL] [Abstract][Full Text] [Related]
30. [Giant-cell myocarditis without a symptom of heart failure seen in a patient with myasthenia gravis and concurrent Hashimoto's disease]. Kanzato N; Nakasone I; Sunagawa O; Komine Y; Fukiyama K Rinsho Shinkeigaku; 2001 Nov; 41(11):813-7. PubMed ID: 12080616 [TBL] [Abstract][Full Text] [Related]
31. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Mahrholdt H; Wagner A; Deluigi CC; Kispert E; Hager S; Meinhardt G; Vogelsberg H; Fritz P; Dippon J; Bock CT; Klingel K; Kandolf R; Sechtem U Circulation; 2006 Oct; 114(15):1581-90. PubMed ID: 17015795 [TBL] [Abstract][Full Text] [Related]
32. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme. Hill GR; Harrison-Woolrych M N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187 [TBL] [Abstract][Full Text] [Related]
33. Strategies to enhance internal validity in multi-center longitudinal research. Smith CS; Salyer J; Geddes N; Mark BA Outcomes Manag Nurs Pract; 1998; 2(4):174-9. PubMed ID: 9919302 [TBL] [Abstract][Full Text] [Related]
34. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Schumann C; Faust M; Gerharz M; Ortmann M; Schubert M; Krone W Exp Clin Endocrinol Diabetes; 2005 May; 113(5):302-7. PubMed ID: 15926118 [TBL] [Abstract][Full Text] [Related]
35. [Giant cell myocarditis]. Iwasaki K; Kusachi S; Hata T; Kita T Ryoikibetsu Shokogun Shirizu; 1996; (14):73-5. PubMed ID: 9047800 [No Abstract] [Full Text] [Related]
36. Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Maisch B; Richter A; Koelsch S; Alter P; Funck R; Pankuweit S Herz; 2006 Dec; 31(9):881-90. PubMed ID: 17180652 [TBL] [Abstract][Full Text] [Related]
37. Do multiinstitutional studies represent a higher level of research than single institution studies? Naftel DC J Heart Lung Transplant; 1996 Mar; 15(3):229-30. PubMed ID: 8777202 [No Abstract] [Full Text] [Related]
38. Development of a database for clinical use and multicenter collaborative data sharing. Knoebel SB J Invasive Cardiol; 1992 Mar; 4(2):99-104. PubMed ID: 10149899 [No Abstract] [Full Text] [Related]
40. Data on giant cell myocarditis sought for new study. Cooper LT; Shabetai R Circulation; 1996 Jan; 93(1):199. PubMed ID: 8616928 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]